P3 Health Partners Statistics
Share Statistics
P3 Health Partners has 358.82M shares outstanding. The number of shares has increased by 210.41% in one year.
| Shares Outstanding | 358.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 201.39M |
| Failed to Deliver (FTD) Shares | 12.57K |
| FTD / Avg. Volume | 1.69% |
Short Selling Information
The latest short interest is 957.12K, so 0.27% of the outstanding shares have been sold short.
| Short Interest | 957.12K |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 1.21 |
Valuation Ratios
The PE ratio is -2.15 and the forward PE ratio is -1.86.
| PE Ratio | -2.15 |
| Forward PE | -1.86 |
| PS Ratio | 0.1 |
| Forward PS | 0 |
| PB Ratio | 0.87 |
| P/FCF Ratio | -1.6 |
| PEG Ratio | n/a |
Enterprise Valuation
P3 Health Partners Inc. has an Enterprise Value (EV) of 208.01M.
| EV / Earnings | -3.6 |
| EV / Sales | 0.16 |
| EV / EBITDA | -2.57 |
| EV / EBIT | -1.24 |
| EV / FCF | -2.67 |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.76.
| Current Ratio | 0.55 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.76 |
| Total Debt / Capitalization | 43.25 |
| Cash Flow / Debt | -0.7 |
| Interest Coverage | -10.5 |
Financial Efficiency
Return on equity (ROE) is -0.41% and return on capital (ROIC) is -30.66%.
| Return on Equity (ROE) | -0.41% |
| Return on Assets (ROA) | -0.07% |
| Return on Capital (ROIC) | -30.66% |
| Revenue Per Employee | 3.17M |
| Profits Per Employee | -144.43K |
| Employee Count | 400 |
| Asset Turnover | 1.47 |
| Inventory Turnover | -341.75 |
Taxes
| Income Tax | 2.69M |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -80.58% in the last 52 weeks. The beta is 1.14, so P3 Health Partners 's price volatility has been higher than the market average.
| Beta | 1.14 |
| 52-Week Price Change | -80.58% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 36.11 |
| Average Volume (20 Days) | 744.13K |
Income Statement
In the last 12 months, P3 Health Partners had revenue of $1.27B and earned -$57.77M in profits. Earnings per share was $-0.61.
| Revenue | 1.27B |
| Gross Profit | 31.64M |
| Operating Income | -167.86M |
| Net Income | -57.77M |
| EBITDA | -81.07M |
| EBIT | -167.86M |
| Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has $36.32M in cash and $121.94M in debt, giving a net cash position of -$85.62M.
| Cash & Cash Equivalents | 36.32M |
| Total Debt | 121.94M |
| Net Cash | -85.62M |
| Retained Earnings | -367.34M |
| Total Assets | 833.33M |
| Working Capital | -190.25M |
Cash Flow
In the last 12 months, operating cash flow was -$76.03M and capital expenditures -$1.83M, giving a free cash flow of -$77.86M.
| Operating Cash Flow | -76.03M |
| Capital Expenditures | -1.83M |
| Free Cash Flow | -77.86M |
| FCF Per Share | -0.82 |
Margins
Gross margin is 2.5%, with operating and profit margins of -13.26% and -4.56%.
| Gross Margin | 2.5% |
| Operating Margin | -13.26% |
| Pretax Margin | -14.51% |
| Profit Margin | -4.56% |
| EBITDA Margin | -6.4% |
| EBIT Margin | -13.26% |
| FCF Margin | -6.15% |
Dividends & Yields
PIII does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -305% |
| FCF Yield | -106.1% |
Analyst Forecast
The average price target for PIII is $2.38, which is 1090% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.38 |
| Price Target Difference | 1090% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.08 |
| Piotroski F-Score | 3 |